...
首页> 外文期刊>Die Pharmazie >Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release.
【24h】

Formulation of PEG-ylated L-asparaginase loaded poly (lactide-co-glycolide) nanoparticles: influence of Pegylation on enzyme loading, activity and in vitro release.

机译:PEG负载L-天冬酰胺酶的聚(丙交酯-共-乙交酯)纳米颗粒的配制:聚乙二醇化对酶负载,活性和体外释放的影响。

获取原文
获取原文并翻译 | 示例

摘要

The present paper describes the advantage of PEG-ylation of L-asparaginase before encapsulation over its incorporation in the native form. During encapsulation a considerable amount of native protein undergoes denaturation and forms insoluble aggregates. In an effort to overcome this problem, L-asparaginase was PEG-ylated before subjecting it to the harsh conditions as encountered during double emulsion solvent evaporation technique. L-asparaginase was conjugated with succinimidyl succinate derivative of polyethylene glycol (SS-PEG, MW 5000) followed by characterization of the formed conjugate using size exclusion-HPLC and SDS PAGE. The PEG-ylated L-asparaginase consisted of different isomers from mono to multi PEG-ylated depending upon the number of Lysine residues (14 in case of L-asparaginase) with about 5% as native protein. The specific activity as retained after PEG-ylation was 62.84 +/- 8.2% and further about 82.7% of activity was recovered from the particles. Imitated studies with the native protein confirmed the enhanced stability of the conjugated protein when exposed to the organic solvent and sonication and showed comparatively less encapsulation efficiency due to increased hydrophilicity. Release profiles for native as well as conjugated proteins consisted of sustained release of about 66.66% and 44.45% in 28 days, respectively. The decrease in the release can be attributed to the increase in the molecular weight of the conjugated protein. The study finally proved that PEG-ylation protected the enzyme and prevented it from denaturation during encapsulation.
机译:本文描述了L-天冬酰胺酶在胶囊化之前的PEG化比以天然形式掺入的优势。在封装过程中,大量的天然蛋白质会变性并形成不溶性聚集体。为了克服这个问题,在使L-天冬酰胺酶经受双重乳液溶剂蒸发技术所遇到的苛刻条件之前,先对其进行PEG化。将L-天冬酰胺酶与聚乙二醇的琥珀酰亚胺基琥珀酸酯衍生物(SS-PEG,MW 5000)缀合,然后使用尺寸排阻-HPLC和SDS PAGE表征形成的缀合物。 PEG-化的L-天冬酰胺酶由不同的异构体组成,从单PEG到多PEG-化,取决于赖氨酸残基的数目(在L-天冬酰胺酶的情况下为14),其中天然蛋白质为约5%。 PEG化后保留的比活性为62.84 +/- 8.2%,并且还从颗粒中回收了约82.7%的活性。用天然蛋白进行的模拟研究证实,当暴露于有机溶剂和超声处理时,缀合蛋白的稳定性增强,并且由于亲水性增加,显示出相对较低的包封效率。天然蛋白和缀合蛋白的释放曲线分别由28天的约66.66%和44.45%的持续释放组成。释放的减少可以归因于结合蛋白的分子量的增加。该研究最终证明,PEG化可保护酶并防止其在封装过程中变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号